NO20062699L - Smelteblandingsdispergeringer - Google Patents

Smelteblandingsdispergeringer

Info

Publication number
NO20062699L
NO20062699L NO20062699A NO20062699A NO20062699L NO 20062699 L NO20062699 L NO 20062699L NO 20062699 A NO20062699 A NO 20062699A NO 20062699 A NO20062699 A NO 20062699A NO 20062699 L NO20062699 L NO 20062699L
Authority
NO
Norway
Prior art keywords
smelteblandingsdispergeringer
bioavailability
dissolution
preparations
enhancing
Prior art date
Application number
NO20062699A
Other languages
English (en)
Inventor
Patrick S L Wong
Liang-Chang Dong
Dong Yan
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20062699L publication Critical patent/NO20062699L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Abstract

Det beskrives preparater eller blandinger, og metoder for å forsterke oppløsningen og biotilgjengeligheten for fordelaktige midler med lav vannoppløselighet.
NO20062699A 2003-11-13 2006-06-12 Smelteblandingsdispergeringer NO20062699L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51958103P 2003-11-13 2003-11-13
PCT/US2004/037615 WO2005048990A2 (en) 2003-11-13 2004-11-12 Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer

Publications (1)

Publication Number Publication Date
NO20062699L true NO20062699L (no) 2006-08-09

Family

ID=34619360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062699A NO20062699L (no) 2003-11-13 2006-06-12 Smelteblandingsdispergeringer

Country Status (13)

Country Link
US (1) US20050106242A1 (no)
EP (1) EP1682092A2 (no)
JP (1) JP2007511518A (no)
KR (1) KR20060123279A (no)
CN (1) CN1901885A (no)
AU (1) AU2004291080A1 (no)
CA (1) CA2545919A1 (no)
IL (1) IL175600A0 (no)
MX (1) MXPA06005461A (no)
NO (1) NO20062699L (no)
TW (1) TW200533374A (no)
WO (1) WO2005048990A2 (no)
ZA (1) ZA200604832B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9744137B2 (en) * 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
AU2007319141B2 (en) 2006-11-17 2013-01-10 Supernus Pharmaceuticals Inc. Sustained-release formulations of topiramate
CN102114002B (zh) * 2006-12-04 2016-05-11 苏佩努斯制药公司 托吡酯的增强的立即释放制剂
EP1972336A1 (en) * 2007-03-19 2008-09-24 LEK Pharmaceuticals D.D. Hot-melt micropellets
KR100958138B1 (ko) * 2008-01-10 2010-05-18 박성순 안정성이 우수한 초산메게스트롤 약학 조성물 및 그제조방법
NO347464B1 (no) * 2010-08-11 2023-11-13 Univ Kansas Forsinkede gelatineringsmidler
WO2013037396A1 (en) * 2011-09-12 2013-03-21 Bioneer A/S Solution of polymer in api for a solid dosage form
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2018089832A1 (en) * 2016-11-10 2018-05-17 University Of Washington Drug-polymer particles with sustained release properties
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
CN107198677B (zh) * 2017-05-25 2021-07-09 长春金赛药业有限责任公司 黄体酮混悬型长效注射剂及其制备方法和黄体酮混悬注射粉针

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
DK0996429T3 (da) * 1997-10-27 2003-05-26 Merck Patent Gmbh Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture
CA2301042A1 (en) * 1998-06-11 1999-12-16 Em Industries, Inc. Micro-osmotic controlled drug delivery systems
ES2372746T3 (es) * 2000-09-20 2012-01-26 Jagotec Ag Micropartículas de fibrato estabilizadas.
CA2452330C (en) * 2001-07-06 2011-03-22 Lifecycle Pharma A/S Controlled agglomeration
US7163700B2 (en) * 2001-07-31 2007-01-16 Capricorn Pharma, Inc. Amorphous drug beads
SE0200895D0 (sv) * 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition

Also Published As

Publication number Publication date
WO2005048990A2 (en) 2005-06-02
US20050106242A1 (en) 2005-05-19
ZA200604832B (en) 2007-12-27
MXPA06005461A (es) 2006-12-15
CN1901885A (zh) 2007-01-24
TW200533374A (en) 2005-10-16
IL175600A0 (en) 2006-09-05
EP1682092A2 (en) 2006-07-26
AU2004291080A1 (en) 2005-06-02
JP2007511518A (ja) 2007-05-10
WO2005048990A3 (en) 2005-10-13
CA2545919A1 (en) 2005-06-02
KR20060123279A (ko) 2006-12-01

Similar Documents

Publication Publication Date Title
NO20062699L (no) Smelteblandingsdispergeringer
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
NO20071095L (no) Hittil ukjente tiofenderivater
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
DK1819353T3 (da) Sammensætning til proteasomhæmning
TR200201187T2 (tr) Ters transkriptazın inhibitörleri olarak benzofenonlar
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
IS7520A (is) Pyrimidínonefnasambönd, samsetningar og aðferðir
HK1079207A1 (en) Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
IS8219A (is) Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
NO20044996L (no) Furylforbindelser
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
NO20032788D0 (no) Modafinil-forbindelse og cyklodekstrinblandinger
DK1248867T3 (da) Selektiv elektrokemisk reduktion af halogenerede 4-aminopicolinsyrer
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
ATE457977T1 (de) Biguanidderivate
NO20053588D0 (no) Acylaminotiazol-derivater, fremstilling og anvendelse derav som beta-amyloidpeptid-produksjonsinhibitorer.
NO20040210L (no) Fenylacetamido-tiazolderivater, fremgangsmate for deres fremstilling og deres anvendelse som antitumormidler
NL1024677A1 (nl) Therapeutische prolinederivaten.
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application